Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

MONOCLONAL ANTIBODIES FOR HUMAN THYMIDYLATE SYNTHASE

  • Read more about MONOCLONAL ANTIBODIES FOR HUMAN THYMIDYLATE SYNTHASE
US Patent 6,221,620
Filed on 1991-04-24

HUMAN DERIVED MONOCYTE ATTRACTING PURIFIED PEPTIDE PRODUCTS USEFUL IN A METHOD OF TREATING INFECTION AND NEOPLASMS IN A HUMAN BODY

  • Read more about HUMAN DERIVED MONOCYTE ATTRACTING PURIFIED PEPTIDE PRODUCTS USEFUL IN A METHOD OF TREATING INFECTION AND NEOPLASMS IN A HUMAN BODY
US Patent 6,090,795
Filed on 1991-04-15

MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT

  • Read more about MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT
US Application 07/684,197
Filed on 1991-04-12

Screening Test That Identifies Individuals at Increased Risk for the Development of Lymphoid Leukemia and Lymphoma

  • Read more about Screening Test That Identifies Individuals at Increased Risk for the Development of Lymphoid Leukemia and Lymphoma
US Application 07/683,685
Filed on 1991-04-11

LIPOPHILIC, AMINOHYDROLASE-ACTIVATED PRODRUGS

  • Read more about LIPOPHILIC, AMINOHYDROLASE-ACTIVATED PRODRUGS
US Patent 5,459,256
Filed on 1991-04-10

INHIBITORS OF PROTEIN KINASE C FUNCTION

  • Read more about INHIBITORS OF PROTEIN KINASE C FUNCTION
US Application 07/681,679
Filed on 1991-04-08

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING SKIN TUMOR FORMATION AND CAUSING REGRESSION OF EXISTING TUMORS

  • Read more about PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PREVENTING SKIN TUMOR FORMATION AND CAUSING REGRESSION OF EXISTING TUMORS
US Application 07/677,429
Filed on 1991-03-29

HYDROXAMIC ACID DERIVATIVES TO INHIBIT VIRAL REPLICATION

  • Read more about HYDROXAMIC ACID DERIVATIVES TO INHIBIT VIRAL REPLICATION
US Application 07/672,577
Filed on 1991-03-20

Treatment of Human Retroviral Infections With 2', 3' -Dideoxyinosine

  • Read more about Treatment of Human Retroviral Infections With 2', 3' -Dideoxyinosine
US Application 07/669,846
Filed on 1991-03-15

MONOCLONAL ANTIBODIES TO CYTOCHROME B5

  • Read more about MONOCLONAL ANTIBODIES TO CYTOCHROME B5
US Application 07/669,090
Filed on 1991-03-15

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1633
  • Page 1634
  • Page 1635
  • Page 1636
  • Page 1637
  • Page 1638
  • Page 1639
  • Page 1640
  • Page 1641
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health